Legal Representation
Attorney
Evan A. Raynes
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 13, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 13, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 28, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 27, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 20, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 27, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 20, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 19, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 19, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 19, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 26, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 23, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 23, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 23, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 29, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 27, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 27, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 27, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 11, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 7, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 7, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 7, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 7, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 12, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 16, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 16, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 27, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 6, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 5, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 22, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 22, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"